MoonLake Immunotherapeutics (MLTX) Other Non-Current Assets (2023 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Other Non-Current Assets of $1.3 million for Q1 2026, down 20.85% year-over-year from $1.7 million in Q1 2025, and up 125.5% quarter-over-quarter from $596000.0 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Other Non-Current Assets (2023 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 20.85% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 20.85% YoY), while the FY2025 annual figure was $596000.0, changed N/A from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.3 million, up from $596000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $8.4 million in Q4 2023, with the low at $587000.0 in Q3 2025.
- The 4-year median for Other Non-Current Assets is $1.7 million (2025), against an average of $3.0 million.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets tumbled 73.13% in 2025, then fell 20.85% in 2026.
- MoonLake Immunotherapeutics' Other Non-Current Assets stood at $8.4 million in 2023, then plunged by 75.49% to $2.1 million in 2024, then tumbled by 71.13% to $596000.0 in 2025, then soared by 125.5% to $1.3 million in 2026.
- Business Quant data shows MLTX's Other Non-Current Assets at $1.3 million in Q1 2026, $596000.0 in Q4 2025, and $587000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 596,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Dec 31, 2023 | 8.42 Mn |